Literature DB >> 24676592

[Operative joint-preserving therapy of gonarthrosis].

S Anders1, J Grifka2, G Heers2.   

Abstract

The guiding principle of operative joint-preserving therapy of gonarthrosis is the search for a safe, minimally invasive, efficient and ultimately reasonably priced therapeutic procedure to preserve or restore joint integrity. A comprehensive analysis and treatment of pathologies adjacent to and distant (axis deviations) from the joint are prerequisites for success of treatment. A comparison of results from the current literature with respect to the operative treatment of arthritis is limited due to the divergence of indications, terminologies used, techniques of the therapeutic procedure, inhomogeneity of patient collectives and the different follow-up and control schemes (scores). Conclusive, prospective, randomized double blind studies with large case numbers are associated with a high degree of organizational effort in planning, patient recruitment and execution and remain a rarity. Long-term prognosis depends on the stage of arthritis at the time of the arthroscopic intervention. Operative measures, such as correction osteotomy can be effective in the early stages. A short duration of symptoms, mechanical blocking and low-grade cartilage damage are factors which have a favorable prognosis. Cell-based cartilage repair techniques can reduce secondary degenerative alterations only in cases of local cartilage damage representing a prearthritic condition. Advantages of autologous chondrocyte transplantation compared to microfracturing have been found depending on the size of the defect and the follow-up time period. Furthermore, preservation and replacement of primary knee stabilizers, such as the anterior cruciate ligament and meniscus, have an important function for secondary prevention. A one-for-all therapy for joint-preserving operative treatment of gonarthrosis is lacking.

Entities:  

Keywords:  Arthritis; Cartilage defect; Cartilage replacement procedure; Chondrocyte transplantation; Joint integrity

Mesh:

Year:  2014        PMID: 24676592     DOI: 10.1007/s00393-013-1319-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  72 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint.

Authors:  Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs
Journal:  Am J Sports Med       Date:  2008-09-18       Impact factor: 6.202

3.  Articular debridement versus washout for degeneration of the medial femoral condyle. A five-year study.

Authors:  M J Hubbard
Journal:  J Bone Joint Surg Br       Date:  1996-03

4.  Outcomes of anterior cruciate ligament reconstruction using single-bundle versus double-bundle technique: meta-analysis of 19 randomized controlled trials.

Authors:  Mai Xu; Shuguang Gao; Chao Zeng; Rui Han; Jinpeng Sun; Hui Li; Yilin Xiong; Guanghua Lei
Journal:  Arthroscopy       Date:  2013-02       Impact factor: 4.772

5.  Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee.

Authors:  J Gille; E Schuseil; J Wimmer; J Gellissen; A P Schulz; P Behrens
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-02       Impact factor: 4.342

6.  First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years' clinical and magnetic resonance imaging follow-up evaluation.

Authors:  Babak Moradi; Eva Schönit; Corinna Nierhoff; Sébastien Hagmann; Doris Oberle; Tobias Gotterbarm; Holger Schmitt; Felix Zeifang
Journal:  Arthroscopy       Date:  2012-10-02       Impact factor: 4.772

Review 7.  [Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT)].

Authors:  P Behrens; U Bosch; J Bruns; C Erggelet; S A Esenwein; C Gaissmaier; T Krackhardt; J Löhnert; S Marlovits; N M Meenen; J Mollenhauer; S Nehrer; F U Niethard; U Nöth; C Perka; W Richter; D Schäfer; U Schneider; M Steinwachs; K Weise
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Sep-Oct

8.  Prevalence of tibiofemoral osteoarthritis 15 years after nonoperative treatment of anterior cruciate ligament injury: a prospective cohort study.

Authors:  Paul Neuman; Martin Englund; Ioannis Kostogiannis; Thomas Fridén; Harald Roos; Leif E Dahlberg
Journal:  Am J Sports Med       Date:  2008-05-15       Impact factor: 6.202

9.  Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis.

Authors:  Tom Minas; Andreas H Gomoll; Shahram Solhpour; Ralf Rosenberger; Christian Probst; Tim Bryant
Journal:  Clin Orthop Relat Res       Date:  2009-08-04       Impact factor: 4.176

10.  The effect of partial meniscectomy on the long-term prognosis of knees with localized, severe chondral damage. A twelve- to fifteen-year followup.

Authors:  W Maletius; K Messner
Journal:  Am J Sports Med       Date:  1996 May-Jun       Impact factor: 6.202

View more
  1 in total

1.  Zonal T2* and T1Gd assessment of knee joint cartilage in various histological grades of cartilage degeneration: an observational in vitro study.

Authors:  Bernd Bittersohl; Harish S Hosalkar; Falk R Miese; Jonas Schibensky; Dietmar P König; Monika Herten; Gerald Antoch; Rüdiger Krauspe; Christoph Zilkens
Journal:  BMJ Open       Date:  2015-02-09       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.